Can acute exacerbations of asthma be prevented with a four-fold increase in inhaled corticosteroid dose?

ottingham City Hospital NHS Trust (UK)0 个研究点目标入组 500 人开始时间: 2005年11月21日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Written Informed consent prior to participation in the trial
•2. Male or female patients 16 years of age or older
•3. Documented diagnosis of asthma
•4. Treatment with 200 to 1000 mcg inhaled beclomethasone dipropionate or equivalent
•5. At least one exacerbation requiring a temporary increase in inhaled corticosteroid or oral corticosteroids in the preceding 12 months
•6. No oral corticosteroids for 4 weeks prior to or during the run-in period

•1. Other respiratory diagnosis or relevant medical condition
•2. Smoking history of greater than 20 pack years
•3. Subjects already using a management plan to deal with exacerbations and who would not wish to be randomised to placebo
•4. Pregnant or nursing women

发起方

ottingham City Hospital NHS Trust (UK)